Skip to content
MedsAcross

Medicine

Sulfamethox-TMP DS 800 mg/160 mg tablet

Available on requestPrescription onlyUS FDA

Sulfamethox-TMP DS 800 mg/160 mg tablet is a prescription medicine containing Sulfamethoxazole and Trimethoprim for oral use, marketed by PharmPak, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20° to 25°C (68° to 77°F).

Key facts

Active ingredient (INN)
Sulfamethoxazole and Trimethoprim
Brand
Sulfamethox-TMP DS
Strength
800 mg/160 mg
Dosage form
Tablet
Route
Oral
Packs
1 bottle and 1 more
Marketing authorisation holder
PharmPak
Manufacturer
PharmPak
Origin register
US FDA, United States
Storage
Store at 20° to 25°C (68° to 77°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
J01EE01 Sulfamethoxazole and Trimethoprim
HS code (indicative)
3004.20Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
11 July 2019
Identifiers
RxCUI 198335DailyMed set ID ede74118-32c5-4f52-9823-509538e674c8NDC 54348-625Application ANDA076899

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

PackCodeLabelerMarketed since
1 bottle in 1 box / 6 tablet in 1 bottle54348-625-06PharmPak11 July 2019
1 bottle in 1 box / 10 tablet in 1 bottle54348-625-10PharmPak11 July 2019
1 bottle in 1 box / 14 tablet in 1 bottle54348-625-14PharmPak11 July 2019
1 bottle in 1 box / 20 tablet in 1 bottle54348-625-20PharmPak11 July 2019

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 30 July 1973Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Sulfamethoxazole and Trimethoprim 800 mg/160 mg tablet.

Compare all 4

Other strengths and forms of Sulfamethoxazole and Trimethoprim

Clinical summary

Sulfamethoxazole and Trimethoprim is a fixed-dose combination of a dihydrofolate reductase inhibitor antibacterial and a sulfonamide antimicrobial indicated for prophylactic or prolonged administration in otitis media at any age. MedsAcross supplies Sulfamethoxazole and Trimethoprim for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Sulfamethoxazole and Trimethoprim

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Sulfamethox-TMP DS 800 mg/160 mg tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.